Harmony Biosciences sets incoming CEO Peter Anastasiou's annual base salary at $725,000

HRMY•2026-10-30

Peter Anastasiou will become Harmony Biosciences' president and CEO on January 1, 2027, with an annual base salary of $725,000 and a target bonus of 75% of salary.

1. CEO compensation terms

An amended filing dated October 30, 2026, sets Peter Anastasiou's annual base salary at $725,000 when he succeeds Jeffrey M. Dayno as president and CEO effective January 1, 2027. His target annual bonus will be 75% of base salary beginning in 2027. His initial equity package includes $1.75 million in options and $750,000 in restricted stock units, which vest over four years subject to continued service. Dayno will receive $500 per consulting hour through January 31, 2028, and will continue to vest in equity or receive full vesting upon a change in control.

Sources

Harmony Biosciences sets incoming CEO Peter Anastasiou's annual base salary at $725,000

Sec

Harmony Biosciences sets incoming CEO Peter Anastasiou's annual base salary at $725,000

1. CEO compensation terms

Related News

Pioneer Bancorp Q3 net income drops on litigation costs

Wall Street closes sharply lower as AI cash burn fears spark tech selloff

Utz Brands CEO Howard Friedman to depart after take-private deal closes

Sources

Harmony Biosciences sets incoming CEO Peter Anastasiou's annual base salary at $725,000

AH Realty Trust brings Harbor Point office portfolio to 98% leased

PowerBank shareholders approve share consolidation, ratio to be set by directors